Market Place
Sourcing Support
All News #Library
Biotech
Starton Files Patents for CAR-T, STAR-LLD in Blood Cancer
05 Mar 2026 //
GLOBENEWSWIRE
Starton Therapeutics Files Patent For Multi-Specific Antibody
26 Feb 2026 //
GLOBENEWSWIRE
Starton Therapeutics Initiates Phase 2A Study Of STAR-LLD
19 Feb 2026 //
GLOBENEWSWIRE
Starton Therapeutics To Present At Biotech Showcase 2026
16 Dec 2025 //
GLOBENEWSWIRE
Starton Therapeutics To Present Lenalidomide Delivery Tech
08 Oct 2025 //
GLOBENEWSWIRE
Starton Tx Promotes Rod Hartwig to VP of R&D and Manufacturing
02 Oct 2025 //
GLOBENEWSWIRE
Starton Therapeutics Secures US Patent for Immunomodulatory Imide
16 Sep 2025 //
GLOBENEWSWIRE
Starton Therapeutics, Bend Partner to Advance STAR-LLD
24 Jun 2025 //
CONTRACTPHARMA
Starton and Bend Partner on Oral STAR-LLD Lenalidomide Form
24 Jun 2025 //
GLOBENEWSWIRE
Starton Opens Ph2a STAR-LLD Trial in Multiple Myeloma
12 Jun 2025 //
GLOBENEWSWIRE
Starton Therapeutics presents positive Phase 1b data on STAR-LLD
25 Apr 2025 //
GLOBENEWSWIRE
Starton Therapeutics to Present at Biotech Showcase 2025
03 Dec 2024 //
GLOBENEWSWIRE
Starton Therapeutics Announces Patent Allowance for Lenalidomide
29 Oct 2024 //
GLOBENEWSWIRE
Starton Therapeutics CEO Honored by Icla da Silva Foundation 2024
24 Sep 2024 //
GLOBENEWSWIRE
Starton Demonstrates STAR-LLD With BD Evolve Injector
18 Sep 2024 //
GLOBENEWSWIRE
Starton Therapeutics Strengthens Clinical Development Strategy
22 Aug 2024 //
GLOBENEWSWIRE
Starton Therapeutics to Present at Biotech Showcase 2024 in San Francisco
18 Dec 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.